Idera Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.83
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
2
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.11
|
0.06
|
0.17
|
154.55%
|
|
2022-06-30
|
-0.11
|
-0.10
|
0.01
|
9.09%
|
|
2022-03-31
|
-0.11
|
-0.08
|
0.03
|
27.27%
|
|
2021-12-31
|
-0.11
|
-0.08
|
0.03
|
27.27%
|
|
2021-09-30
|
-0.12
|
-0.11
|
0.01
|
8.33%
|
|
2021-06-30
|
-0.18
|
-0.15
|
0.03
|
16.67%
|
|
2021-03-31
|
-0.21
|
2.66
|
2.87
|
1366.67%
|
|
2020-12-31
|
-0.23
|
-2.11
|
-1.88
|
-817.39%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.12
|
|
2021-12-31
|
2.32
|
|
2020-12-31
|
-3.20
|
|
2019-12-31
|
-2.94
|
|
2018-12-31
|
-2.27
|
|
2017-12-31
|
-3.36
|
|
2016-12-31
|
-0.94
|
|
2015-12-31
|
-0.43
|
|
2014-12-31
|
-2.01
|
|
2013-12-31
|
-4.08
|
|
2012-12-31
|
-6.49
|
|
2011-12-31
|
-8.24
|
|
2010-12-31
|
-5.68
|
|
2009-12-31
|
2.57
|
|
2008-12-31
|
0.32
|
|
2007-12-31
|
-4.96
|
|
2006-12-31
|
-13.68
|
|
2004-12-31
|
-10.88
|
|
2003-12-31
|
-13.61
|
|
2001-12-31
|
-16.76
|
|
2000-12-31
|
-215.31
|
|
1997-12-31
|
-633.60
|
|
1996-12-31
|
-329.60
|